Fabio Fagundes Rocha

Fabio Fagundes Rocha

Auto-generated profile, based on publicly available information

Fabio Fagundes Rocha

Department of Physiological Sciences, Institute of Biology, Federal Rural University of Rio de Janeiro, Seropédica, RJ, Brazil

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GMGiany O. De Melo
Giany O. De Melo
DMDavid Do C. Malvar
David Do C. Malvar
FVFrederico A. Vanderlinde
Frederico A. Vanderlinde
FRFabio F. Rocha
Fabio F. Rocha
PPPriscila Andrade Pires
Priscila Andrade Pires
SCSônia Soares Costa
Sônia Soares Costa

1 June 2007 in Phytomedicine
Verified
Journal Article
Closed access
FRF.F. Rocha
F.F. Rocha
MLM.T.R. Lima-Landman
M.T.R. Lima-Landman
CSC. Souccar
C. Souccar
MTM.M. Tanae
M.M. Tanae
TLT.C.M. De Lima
T.C.M. De Lima
ALA.J. Lapa
A.J. Lapa

1 January 2002 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
FRF.F. Rocha
F.F. Rocha
ALA.J. Lapa
A.J. Lapa
TLT.C.M. De Lima
T.C.M. De Lima

11 June 2014 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
JFJames Oluwagbamigbe Fajemiroye
James Oluwagbamigbe Fajemiroye
PGPablinny M Galdino
Pablinny M Galdino
IFIziara F Florentino
Iziara F Florentino
FRFabio F Da Rocha
Fabio F Da Rocha
PGPaulo César Ghedini
Paulo César Ghedini
ECElson A Costa
Elson A Costa
Our study sought to evaluate the anxiolytic and antidepressant activities of oleanolic acid as well as the neural mechanisms involved. Animal models such as barbiturate sleep-induction, light–dark box, elevated plus maze, forced swimming test, tail suspension test and open field test were conducted. Male Albino Swiss mice were treated orally with vehicle 10 mL/kg, fluoxetine 20 mg/kg, imipramine 15 mg/kg, diazepam 1 mg/kg or oleanolic acid 5–40 mg/kg. Pretreatment (intraperitoneal) of animals with pentylenetetrazole (PTZ) 20 mg/kg, 1-(2-methoxyphenyl)-4-[4- (2-phthalimido) butyl]piperazine hydrobromide (NAN-190) 0.5 mg/kg, p-chlorophenylalanine methyl ester (PCPA) 100 mg/kg or α-methyl-p-tyrosine (AMPT) 100 mg/kg, WAY100635 (WAY) 0.3 mg/kg, prazosin (PRAZ) 1 mg/kg, yohimbine 2 mg/kg as well as monoamine oxidase assay and hippocampal brain-derived neurotrophic factor (BDNF) quantification were carried out. Oleanolic acid potentiated the hypnotic effect of barbiturate and demonstrated an anxiolytic effect in both the light–dark box and elevated plus maze. This effect was not reversed by PTZ. Acute and/or chronic oral treatment of mice with oleanolic acid (5−20 mg/kg) elicited an antidepressant effect in the forced swimming test and the tail suspension test without interfering with the locomotor activity. The antidepressant effect of oleanolic acid was attenuated by NAN-190, AMPT, PCPA, WAY and PRAZ. Although monoamine oxidase activity remained unaltered by oleanolic acid, chronic administration of oleanolic acid augmented hippocampal BDNF level. These findings demonstrate multiple mechanisms of the anxiolytic and antidepressant effect of oleanolic acid.

1 January 2012 in Neuropharmacology
Verified
Journal Article
Closed access
EOEmerson L. Olivares
Emerson L. Olivares
CSCláudio Silva-Almeida
Cláudio Silva-Almeida
FPFernanda M. Pestana
Fernanda M. Pestana
RSRafael Sonoda-Côrtes
Rafael Sonoda-Côrtes
IAIracema G. Araujo
Iracema G. Araujo
FRFábio F. Rocha
Fábio F. Rocha

28 April 2014 in Food & Function
Verified
Journal Article
Closed access
PDF file
JFJames Oluwagbamigbe Fajemiroye
James Oluwagbamigbe Fajemiroye
PGPablinny Moreira Galdino
Pablinny Moreira Galdino
JPJoelma Abadia Marciano de Paula
Joelma Abadia Marciano de Paula
FRFagundes Fabio Rocha
Fagundes Fabio Rocha
MAMoses A. Akanmu
Moses A. Akanmu
ECElson Alves Costa
Elson Alves Costa
(E)-methyl isoeugenol (MIE) is a natural food flavour that constitutes 93.7% of an essential oil from Pimenta pseudocaryophyllus leaf. The leaf extracts of this species are used as a calming agent. As a ubiquitous food additive, the application of MIE for treating mood disorders appears to be globally attractive. Hence, we sought to evaluate general pharmacological activities, anticonvulsant, anxiolytic and antidepressant effects and the possible mechanisms of MIE actions. Administration of MIE was carried out prior to the exposure of a male Swiss mice to general behavioural tests, barbiturate sleep, PTZ-induced convulsion, light dark box (LDB), elevated plus maze (EPM), wire hanging, open field (OF) and forced swimming test (FST). The involvement of monoamine system was studied by mice pretreatment with WAY100635 (antagonist of 5-HT1A), α-methyl-p-tyrosine (AMPT; depletor of catecholamine) or p-chlorophenylalanine (PCPA; depletor of serotonin storage). There was no record of neurotoxic effect or animal's death during the course of general pharmacological tests. MIE at 250 and 500 mg kg−1 potentiated the hypnotic effect of sodium pentobarbital. However, MIE did not protect against PTZ-induced convulsion. Except for MIE at 500 mg kg−1, parameters evaluated in the LDB, EPM and OF demonstrated an anxiolytic like property of MIE. This effect was blocked by WAY100635 pretreatment. MIE at 500 mg kg−1 elicited a reduction in locomotor activity of the mice in the OF. Anti-immobility effect of MIE 250 mg kg−1 in the FST suggested an antidepressive like property. Unlike AMPT, pretreatment with PCPA reversed the antidepressant like effect of MIE. Our findings demonstrated anxiolytic and antidepressant like properties of (E)-methyl isoeugenol and suggested the participation of serotonergic pathways.